Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W M Martens

Showing results (1-10 of 316) with videos related to

Pageof 32
Sort By:
Frontiers in Genetics|August 18, 2018
Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS AnalysesMahdi Rivandi, John W M Martens, Antoinette Hollestelle
Drug Discovery Today|June 7, 2019
Incorporating liquid biopsies into treatment decision-making: obstacles and possibilitiesNick Beije, John W M Martens, Stefan Sleijfer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2-positive breast cancer?John A Foekens, John W M Martens, Stefan Sleijfer
International Journal of Molecular Sciences|May 14, 2022
Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal CancerMarcel Smid, Saskia M Wilting, John W M Martens
Cancers|February 15, 2022
Identifying Transcripts with Tandem Duplications from RNA-Sequencing Data to Predict BRCA1-Type Primary Breast CancerShuoying Qu, John W M Martens, Antoinette Hollestelle, et al.
Current Opinion in Genetics & Development|March 30, 2010
Discovering moderate-risk breast cancer susceptibility genesAntoinette Hollestelle, Marijke Wasielewski, John W M Martens, et al.
Genome Biology|December 18, 2016
A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrenceSander Canisius, John W M Martens, Lodewyk F A Wessels
Drug Discovery Today|March 27, 2019
The role of mitochondrial DNA in breast tumorsMarjolein J A Weerts, Stefan Sleijfer, John W M Martens
Breast Cancer Research and Treatment|May 24, 2011
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancerMusaffe Tuna, Marcel Smid, John W M Martens, et al.
Current Opinion in Oncology|July 18, 2020
Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratificationLisanne F van Dessel, John W M Martens, Martijn P Lolkema
Pageof 32

Showing results (1-10 of 316) with videos related to

Sort By:
Pageof 32
Frontiers in Genetics|August 18, 2018
Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS AnalysesMahdi Rivandi, John W M Martens, Antoinette Hollestelle
Drug Discovery Today|June 7, 2019
Incorporating liquid biopsies into treatment decision-making: obstacles and possibilitiesNick Beije, John W M Martens, Stefan Sleijfer
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 22, 2015
Are immune signatures a worthwhile tool for decision making in early-stage human epidermal growth factor receptor 2-positive breast cancer?John A Foekens, John W M Martens, Stefan Sleijfer
International Journal of Molecular Sciences|May 14, 2022
Lost by Transcription: Fork Failures, Elevated Expression, and Clinical Consequences Related to Deletions in Metastatic Colorectal CancerMarcel Smid, Saskia M Wilting, John W M Martens
Cancers|February 15, 2022
Identifying Transcripts with Tandem Duplications from RNA-Sequencing Data to Predict BRCA1-Type Primary Breast CancerShuoying Qu, John W M Martens, Antoinette Hollestelle, et al.
Current Opinion in Genetics & Development|March 30, 2010
Discovering moderate-risk breast cancer susceptibility genesAntoinette Hollestelle, Marijke Wasielewski, John W M Martens, et al.
Genome Biology|December 18, 2016
A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrenceSander Canisius, John W M Martens, Lodewyk F A Wessels
Drug Discovery Today|March 27, 2019
The role of mitochondrial DNA in breast tumorsMarjolein J A Weerts, Stefan Sleijfer, John W M Martens
Breast Cancer Research and Treatment|May 24, 2011
Prognostic value of acquired uniparental disomy (aUPD) in primary breast cancerMusaffe Tuna, Marcel Smid, John W M Martens, et al.
Current Opinion in Oncology|July 18, 2020
Fundamentals of liquid biopsies in metastatic prostate cancer: from characterization to stratificationLisanne F van Dessel, John W M Martens, Martijn P Lolkema
Pageof 32